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ABSTRACT
Objective: to analyze the sociodemographic and clinical characteristics of patients with valvular heart disease and to verify 
the infl uence of these variables on the impact of valve disease in daily life. Method: the study involved 86 outpatients. Data 
collection was performed in two stages – face-to-face interview for sociodemographic and clinical characterization and through 
telephone contact for the application of the Instrument to Measure the Impact of Valvular Heart Disease on Patient’s Everyday 
Life (IDCV). Data were analyzed through descriptive statistics and multiple regression analysis. Results: it was noticed that the 
total score of IDCV and its domains were infl uenced by age, schooling, presence or absence of symptoms, use or not of diuretic. 
Conclusion: The impact of the disease was infl uenced by sociodemographic and clinical variables. The results provide subsidies 
for the design of nursing interventions aimed at reducing the impact of the disease on the patient’s daily life with valve disease.
Key words: Nursing; Impacts on Health; Valvular Heart Diseases; Impact Profi le of the Disease; Questionnaires.
RESUMO
Objetivo: analisar as características sociodemográfi cas e clínicas dos pacientes com valvopatia e verifi car a infl uência dessas 
variáveis no impacto da valvopatia no cotidiano. Método: participaram do estudo 86 pacientes em seguimento ambulatorial. 
A coleta de dados foi realizada em duas etapas - entrevista presencial para caracterização sociodemográfi ca e clínica e por 
meio de contato telefônico para aplicação do Instrumento para Mensuração do Impacto da Doença no Cotidiano do Valvopata 
(IDCV). Os dados foram analisados através de estatística descritiva e análise de regressão múltipla. Resultados: constatou-se que 
o escore total do IDCV e seus domínios foram infl uenciados pela idade, escolaridade, presença ou não de sintomatologia, uso 
ou não de diurético. Conclusão: o impacto da doença foi infl uenciado por variáveis sociodemográfi cas e clínicas. Os resultados 
fornecem subsídios para o delineamento de intervenções de enfermagem com vistas à redução do impacto da doença no 
cotidiano do paciente com valvopatia.
Descritores: Enfermagem; Impactos na Saúde; Doenças das Valvas Cardíacas; Perfi l de Impacto da Doença; Questionários.
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INTRODUCTION
In recent decades, chronic diseases have played an important 
role in morbidity and mortality of the world population reach-
ing the elderly and young people of working-age(1). Among the 
chronic diseases, there is the cardiovascular disease (CVD) rep-
resenting a large number of hospitalizations, are the major cause 
of death throughout the country and also one of the diseases that 
constitute a major burden to the health system(2).
In the CVD’s group, valvulopathies represent a disease 
in evolution, resulting from various factors, including the in-
crease of degenerative valve disease, due to the population 
aging and those of rheumatic origin(3).
The prevalence of valvular heart disease, although to a 
lesser magnitude compared to the prevalence of other CVD, 
represents one of the main sources of health care and health 
resources consumption(3). Despite the high incidence of val-
vular heart disease in Brazil, data on its actual prevalence and 
clinical profile are scarce(2).
Living with a chronic disease such as valvular heart dis-
ease, with its symptoms and the stigma that a heart disease 
can represent, results in physical, psychological and social 
commitment since this patient lives with the possibility of a 
new decompensation or worsening the clinic condition de-
spite the appropriate treatment(4-5). Therefore, the assistance 
to these patients should include, in addition to care related 
to biological aspects, those related to psychosocial variables, 
especially considering their health self-perception(5-6).
Health self-perception refers to the interpretation of the in-
dividual about health experiences based on their knowledge 
and information. This judgment is often influenced by their 
experience and by social and cultural norms(6). Also, studies 
suggest that variables not related to the disease, such as low 
socioeconomic level (characterized by total years of study, by 
the performed activity and by income) and behavioral aspects, 
such as smoking, alcoholism, and illicit drug use also influ-
ence the concept of health perception(7).
Kusumota(8) reports that variables such as age, gender, 
schooling, presence of comorbidities, among others, are im-
portant factors in determining the impact of the disease in pa-
tients with chronic disease. 
Thus, considering the importance of deepening the knowl-
edge about the impact of valvular heart disease in daily life, 
this study aimed to analyze the sociodemographic and clini-
cal characteristics of patients with valvular heart disease and 
to verify the influence of these variables on the impact of 
valvular heart disease in the daily life of these patients. The 
findings of this study provide subsidies for the development 
of nursing interventions aimed at reducing the impact of the 
valvular heart disease on outpatient’s every day.
METHOD
It is an exploratory study performed in a specialized car-
diology clinic of a large university hospital in the state of São 
Paulo. 
86 patients with mitral valvular disease and/or aortic were 
part of this study, of both sexes, aged over 18 years old, sub-
mitted to clinical and/or surgical treatment in outpatients of 
this service. Patients who presented inability to effective oral 
verbal communication were excluded.
As this study was clipping of progress study aimed to vali-
date the CVID by the patients with valvular heart disease and 
outpatients(9), the sample size was estimated according to the 
recommended for validation studies, i.e., 100 participants(10). 
However, due to losses in the data collection stage, the final 
sample consisted of 86 patients.
Data were collected through personal interview carried out 
individually by the researcher to obtain the sociodemographic 
and clinical data and by telephone contact for the application 
of CVID, as specified below:
• First step: the patient is in the initial approach and ex-
planations about the study objectives and the patient’s 
agreement obtainment to participate in the study by 
signing the Informed Consent (IC). The patient was in-
structed that the participation in the study would involve 
the application of a questionnaire through telephone 
contact. After consent, available data recording method 
was employed to obtain information from medical re-
cords that allowed the sociodemographic and clinical 
characterization of study participants. Then, through the 
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structured interview technique, the sociodemographic 
and clinical not available data in the medical records 
were obtained.
• Second step: the CVID was applied through telephone 
contact of the participants who agreed to participate in 
the research in the first stage. The literature recommenda-
tions were carefully followed for data collection through 
telephone contact. . In this sense, the study by Costa et 
al.(11) pointed to the invariance in performance scales used 
in different application groups - in person or by telephone, 
suggesting that telephone contact is a reliable strategy for 
obtaining data compared to attendance application, be-
sides being effective, low-cost and accessible.
Sociodemographic and clinical characterization
Used for survey of interest information to outline the so-
ciodemographic and clinical profile of the participants, the 
instrument was developed by Mendez et al.(12), composed of 
open and closed questions, divided into two large items.:
• Sociodemographic characterization: allows data collec-
tion, such as: age, gender, race, schooling, marital sta-
tus, with whom they live, employment, individual and 
family monthly income and origin.
• Clinical characterization: data collection, such as: medi-
cal diagnosis, type of treatment, time since diagnosis of 
valvular heart disease, signs, and symptoms of the last 
month and medicines in use.
Instrument to measure the Impact of Valvular Heart Dis-
ease on Patient’s Everyday Life (CVID)
A tool developed and validated by Padilha et al.(9,13) to eval-
uate the impact of valvular heart disease in daily life activities 
of the patient. The CVID is composed of two scales, the first 
measures the perceptions regarding the impact of the disease. 
The patient should answer each item using a Likert scale of 
five points, ranging from (1) strongly disagree to (5) strongly 
agree. The second scale measures the evaluation that the sub-
ject does on each consequence of valvular heart disease men-
tioned in the first scale (happening or not in their life) request-
ing to the participant to situate its evaluation for a Likert scale, 
whose answers range from (1) very bad (5) very good. The 
items are divided into four domains: Physical disease impact 
- symptoms (11, 12 and 13 items), Impact of disease on daily 
activities (5, 7, 9, 10 and 14), Social and emotional impact of 
the disease (2, 3, 4 and 6 items) and Adaptation to the disease 
(1 and 8). To determine the final score of CVID, all items of 
Part B were reversed. Items 1, 5 and 8 of Part A, which corre-
spond to perceptions related to the favorable impact also had 
their inverted scores. The score of each item corresponds to 
the product of the scores obtained in Parts A and B of CVID 
and can generate a minimum score of 1 and a maximum of 
25 for each evaluated affirmative. The closer to the score 1, 
the lower the impact perceived by the subject to a given be-
lief and the closer to 25 the stronger the impact. For the final 
calculation of the measure of the impact, it is made the sum 
of all the obtained products. The final score of the instrument 
may vary from 14 to 350; the lower the score, the less the 
patient perceives the impact of the negative consequences of 
the disease in their life and does not evaluate as bad those 
consequences, if occurs (i.e., the lower the impact of the dis-
ease); the higher the score it means the patient recognizes 
the occurrence of the negative consequences of the disease 
on their lives and those consequences are, in fact, interpret-
ed as negative (i.e., the greater the impact of the disease on 
daily activities). In the study that originated the instrument, it 
was found satisfactory internal consistency for the total CVID 
through Cronbach’s alpha coefficient (α = 0.86). The other 
domains also show evidence of satisfactory internal consis-
tency - Physical Impact of Disease - Symptoms (α = 0.71); 
Impact of Disease in Activities of Daily Living (α = 0.79); 
Social and emotional impact of the disease (α = 0.72) (9,13). 
The adaptation to the disease domain, as in other studies that 
evaluated the psychometric properties of the instrument(9,13-15), 
has shown no evidence of reliability (α = -0.008). In the pres-
ent study, it was found Cronbach’s alpha = 0.86 for the total 
score of CVID.
Data analysis
The collected data were inserted into an electronic spread-
sheet (Excel software, 2003) and transferred to the SAS - Sys-
tem for Windows (Statistical Analysis System), version 8.2, for 
the following analyzes:
• Descriptive: with a confection of frequency tables, position 
measurements (medium, median, minimum and maxi-
mum) and dispersion (standard deviation) for data of so-
ciodemographic and clinical instrument and CVID scores.
• Reliability: with the use of Cronbach’s alpha coefficient 
to estimate the internal consistency of CVID, i.e., homo-
geneity and accuracy of the items. It was established as 
evidence of satisfactory internal consistency, the value 
of Cronbach’s alpha coefficient > 0.70. 
• Multiple linear regression: with Stepwise criterion to 
test the influence of sociodemographic and clinical vari-
ables on the impact of the disease, evaluated by CVID. 
It was adopted as significance level of p< 0.05.
The study was approved by the Research Ethics Committee of 
a university in the state of São Paulo, through an addendum to the 
opinion of approval of progress study developed by our research 
group(13). All enrolled patients signed the Informed Consent.
RESULTS
Sociodemographic and Clinical Characterization
The study enrolled 86 subjects, whose sociodemographic 
characteristics are presented in Table 1.
It was found that just over half of the sample consists of 
women (58.1%), white (59%), median age of 52.7 years-
old (12.9), married (55.8%), living with spouse and children 
(41.9%), with median 6.4 of study (3.2) inactive years (47.7%), 
with a monthly average individual income of 1.9 (1.2) mini-
mum wages (MW) and average monthly family income of 2.9 
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Table 1 - Sociodemographic and clinical characteristics of outpatients with valvular heart disease at a university hospital (N = 86), 
Campinas, São Paulo, Brazil, 2012
Sociodemographic variables % Average (sd) Median Variation
Gender
Female 58.1
Breed
White 59.0
Age (years old) 52.7(12.9) 54.0 18-77
Schooling (in years, n=79) 6.4(3.2) 5.0 0.5-18
Marital Status 
Married 55.8
Separated/Divorced 12.8
Concubinage 11.6
Widower 11.6
Single 8.1
Living with
With spouse and children 41.9
With spouse 22.1
Others 30.2
Alone 5.8
Employment 
Inactive 47.7
Active 34.9
Housewife 17.4
Individual Income (SM†, n=64) 1.9(1.2) 1.6 0.3-8.0
Familiar Income (SM, n=85) 2.9(1.9) 2.3 0.4-9.6
Origin
 Metropolitan Region of Campinas 54.6
Campinas 23.3
Other cities of São Paulo 19.8
Outros States 2.3
Clinical Diagnosis
Single Injury 37.2
Double Injury 31.4
Type of valvular heart disease 
Mitral Insufficiency                            59.3
Mitral Stenosis 50.0
Aortic Insufficiency                                        47.7
Aortic Stenosis                                            34.9
Symptoms 
Fatigue                                 52.5
Dyspnea                               50.0
Tachycardia                           47.7
Chest Pain 43.0
Syncope                                39.5
Edema 37.2
Treatment  
Clinical and surgical 71.3
Clinical 25.6
Treatment time (in years) 14.1(12.6) 10.0 5.0-20.0
Number of medications in use 4.4(2.1) 4.0 0-10
Notes: Standard Deviation; †minimum wage of R$ 622.00, Brazil, in 2012.
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(1.9) MW. Most (54.6%) came from the metropolitan region of 
Campinas, 23.3% were from the city of Campinas, 19.8% of 
other cities of São Paulo and 2.3% from other states.
Considering the clinical diagnosis, 37.2% of patients have a 
single injury in a single valve apparatus, and 31.4% had a dou-
ble injury. Fatigue (52.5%) and dyspnea (50%) were the most 
frequently reported symptoms. The average time from the start 
of treatment was 14.1 (12.6) years. Most participants (71.3%) 
had clinical treatment and had undergone surgical treatment; 
consumed on average 4.4 (SD = 2.1) types of medication a day.
Influence of sociodemographic and clinical variables on 
the impact of the disease on daily activities
The results of the multiple linear regression analysis with 
Stepwise selection criteria of variables - used to verify the in-
fluence of sociodemographic and clinical variables on the im-
pact of the disease evaluated by the total CVID and domains 
are presented in Table 2.
The data showed that schooling and age were the sociodemo-
graphic variables that influenced the impact of valvular heart dis-
ease in the daily activities of these people. Schooling influenced 
the impact in two areas - Physical impact - Symptoms (p = 0.0458) 
and in Social and Emotional Impact domain (p = 0.0012). The 
age, in turn, influenced the domain of Illness Adaptation.
The impact of the disease was still influenced by clinical 
variables - symptoms related to valvular heart disease (dys-
pnea, palpitations, chest pain and fainting) and diuretic use. 
The perception of palpitations self-reported by the patient 
influenced the total CVID and three of its domains - Impact on 
Daily Living Activities (p value < 0.0001), Social and Emo-
tional Impact of the disease (p = 0.0033) and Adaptation do-
main to the Disease (p = 0.0003).
Similarly, the use of diuretic influenced the domains Physi-
cal Symptoms Impact (p = 0.0248), Social and Emotional Im-
pact (p = 0.0112) and the total score (p = 0.0005).
It was found that the total CVID was influenced by the pres-
ence of symptoms - chest pain (p = 0.0027), palpitations (p = 
0.0097) and diuretic use (p = 0.0005).
DISCUSSION
This study analyzed the sociodemographic and clinical char-
acteristics of patients with valvular heart disease and verified 
the influence of these variables on the impact of valvular heart 
disease in the daily life of these patients. The main findings 
showed that the impact of the disease in this group of patients 
was influenced by sociodemographic characteristics such as: 
age, schooling and the clinical variables - symptoms (dyspnea, 
palpitations, fainting and chest pain) and diuretics use. 
Concerning the sociodemographic characteristics of the 
study group, the composition of the sample studied showed 
that gender and age proved the evidence presented by other 
studies about valvular heart disease - mostly female patients, 
with ages ranging from 18 to 75 years-old(9,13). The schooling 
and socioeconomic status in the studied group re-
flect the majority of the population served in a uni-
versity hospital, which provides health care through 
the Unified Health System (UHS), predominantly 
made up of individuals with low schooling and low-
er socioeconomic status. Similar results were found 
in studies performed with cardiac patients treated at 
the same hospital(9,13-17).
It was found that 47.7 (41/86) of respondents 
were inactive, i.e., received the disease benefit, 
were retired due to disability or length of service 
or were unemployed. In this group of a variable 
labor situation, it seems possible to affirm that the 
clinical manifestation of valvular heart disease may 
have contributed to withdraw early the subject of 
productive life, with negative consequences for the 
individual and society.
Concerning diagnosis, 59.3% of participants had 
a diagnosis of mitral insufficiency and 50% mitral 
stenosis. The involvement of the mitral valve has a 
high incidence in the population, unlike most de-
veloped countries, being rheumatic fever the main 
cause of valvular heart disease in our country, re-
sponsible for 70% of cases(18). 
Drug therapy in valvular heart disease aims to 
control consequences and prevent complications. 
Pharmacological groups applicable to valvular heart 
disease are: digitalis, beta-blockers, diuretics, va-
sodilators, antiarrhythmic and anticoagulants(3,5). In 
this study, it was found that all patients were using 
Table 2 - Multiple linear regression analysis used to test the in-
fluence of sociodemographic and clinical variables in 
the perception of the impact of the disease on daily ac-
tivities of patients with valvular heart disease (N = 86), 
Campinas, São Paulo, Brazil, 2012
Dependent variable Independent variable p value
Physical Impact – Symptoms
Schooling 0.0458
Dyspnea 0.0007
Diuretics use 0.0248
Fainting 0.0001
Daily Living Activities Impact Palpitation 0.0187
Social and Emotional Impact
Schooling 0.0012
Palpitation 0.0033
Diuretics use 0.0112
Illness Adaptation
Age 0.0027
Palpitation 0.0003
Fainting 0.0073
CVID – Total
Diuretic use 0.0005
Chest pain 0.0027
Palpitation 0.0097
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the drug therapy. In medical records research, it was found 
using the following drug classes: digitalis, diuretics, vasodila-
tors inhibitors (ACE) and anticoagulants therefore in line drug 
classes recommended in the literature. 
The valvular heart disease patients are characterized by 
presenting signs and symptoms, such as: dyspnea, fatigue, 
syncope, edema, chest pain and palpitations that manifest 
daily and progressively with the evolution of the disease 
which leads patients to seek medical attention in the progres-
sive worsening of their physical symptoms, usually fatigue and 
dyspnea(3,5,18). In this study, it was found that 80.2% of patients 
had at least one symptom described in the literature, the most 
prevalent fatigue (53.5%) and dyspnea (50%), confirming the 
findings of previous studies.
The results of this study suggest that sociodemographic 
variables such as schooling and age influence the perception 
of the impact of the disease. The relationship between school-
ing and the perception that the patient has the disease has also 
been identified in progress study, in which we observed the 
influence of schooling level about the existence of inadequate 
beliefs so that participants with more than four years of educa-
tion reported more inappropriate beliefs(19).
The literature has shown in recent years, concern for an 
association between schooling level and clinical and psycho-
social variables, and suggested a correlation between them, 
i.e., the lower the schooling level, the worse the clinical evo-
lution and the psychosocial variables results are less favorable 
(beliefs, attitudes or disease perceptions). These findings cor-
roborate with Reis and Glashan study(19) developed with hy-
pertensive and was observed that patients with higher school-
ing levels were also the most enlightened as to the severity of 
hypertension. 
Similarly, the presence or absence of symptoms seems to 
be important not only to evaluate the clinical evolution of 
the individual but also to assist in the understanding of the 
impact of the disease and treatment in their life. Symptoms 
influenced the perception of the subject about the impact of 
disease related to activities of daily living, social and emo-
tional factors and physical and related to adaptation to living 
conditions. Thus, it is believed that the symptoms should be 
addressed from a clinical point of view, as evidence of im-
provement or worsening of the clinical condition or to assess 
the effectiveness of the treatment and, especially, in the view 
of the subject, assessing the impact on daily life activities and 
especially helping the patient to develop strategies for preven-
tion, relief and/or addressing the symptoms.
The results of this study demonstrated that the use of di-
uretic influence the perception of impact with regard to the 
social, emotional and physical aspects - symptoms that can be 
attributed to the fact that drug relate to the relief of dyspnea 
and edema lower limbs, common symptoms of valvular heart 
disease that significantly impair their daily lives by the restric-
tions in the development of daily living activities. 
Another aspect associated with diuretic treatment refers to 
the nuisance caused by their use, while providing relief of 
symptoms, can cause restrictions in the lives of these patients 
as it increases the urinary volume, which can interfere with or 
impede the patient to frequent places where there is no easy 
access to the bathroom. Often, we heard the difficulty of rec-
onciling taking the drug for the maintenance of work activities 
and/or leisure. 
It constitutes a limitation of this study, including the sample 
of medical and surgical patients, whose perception of the im-
pact of the disease on daily activities can differ by the kind of 
applied treatment, although the average length of treatment 
(14.1 years) and the median (10 years) point to the coexistence 
for a long time with the disease and its clinical outcomes. 
Thus, the results regarding the influence of sociodemo-
graphic and clinical variables in the perception of the impact 
of the disease are essential for the planning of care/nursing 
actions for these clients. This knowledge allows nurses to de-
velop strategies aimed at controlling or reducing predictors 
of a worse impact of the disease and/or how to direct specific 
actions for those most vulnerable to a worse impact, such as 
those with low schooling. 
CONCLUSION
Our findings show that the studied group is characterized 
by low socioeconomic status represented by low schooling 
and low income. The impact perceived by the disease was 
influenced by sociodemographic variables such as age and 
schooling and clinical variables such as the presence or ab-
sence of symptoms and diuretics treatment. It is considered 
therefore that knowledge about the sociodemographic and 
clinical characteristics and their influence on the impact dis-
ease perception is an important strategy for the quality of care 
provided to outpatients with valvular heart disease.
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